- Home
- PROF
as 07-26-2024 4:00pm EST
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 238.5M | IPO Year: | N/A |
| Target Price: | $11.40 | AVG Volume (30 days): | 40.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.11 - $12.37 | Next Earning Date: | 08-08-2024 |
| Revenue: | $5,330,147 | Revenue Growth: | 1.00% |
| Revenue Growth (this year): | 57.79% | Revenue Growth (next year): | 195.06% |
Latest Profound Medical Corp. News
PROF Breaking Stock News: Dive into PROF Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
GlobeNewswire
16 days ago
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
Simply Wall St.
2 months ago
Insider Stock Buying Reaches US$781.1k On Profound Medical
GlobeNewswire
2 months ago
Profound Medical Annual General Meeting of Shareholders Voting Results
CNW Group
2 months ago
PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS
GlobeNewswire
2 months ago
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
Simply Wall St.
3 months ago
Profound Medical First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
GlobeNewswire
3 months ago
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
Compare PROF vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PROF Profound Medical Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.